Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
emixustat hydrochloride (formerly ACU-4429)
print preview
bookmark
share with colleague
General Information
Company
Acucela Inc.
Description
Non-retinoid visual cycle modulator
Molecular Target
Mechanism of Action
Latest Stage of Development
Phase II/III
Indication
Age-related macular degeneration (AMD)
Partner
Otsuka Pharmaceutical Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information